These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30821562)

  • 1. Adjunctive gentamicin did not improve outcome of enterococcal bacteraemia in neutropenic patients: a propensity scored matched study.
    Jent P; Thalmann L; Pabst T; Droz S; Sendi P
    Infect Dis (Lond); 2019 Jun; 51(6):409-416. PubMed ID: 30821562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
    Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
    BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy.
    Suppli M; Aabenhus R; Harboe ZB; Andersen LP; Tvede M; Jensen JU
    Clin Microbiol Infect; 2011 Jul; 17(7):1078-83. PubMed ID: 20946408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
    Ombandza-Moussa E; Schlegel L; Vekhoff A; Gerbal R; Marie JP; Bouvet A
    Pathol Biol (Paris); 2002 Apr; 50(3):169-77. PubMed ID: 11980330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian Enterococcal Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Pearson JC; Daly DA; Le TT; Robinson JO; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E320-6. PubMed ID: 25631594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A febrile neutropenic patient with Enterococcus gallinarum sepsis treated with daptomycin and gentamicin.
    Barber GR; Lauretta J; Saez R
    Pharmacotherapy; 2007 Jun; 27(6):927-32. PubMed ID: 17542774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterococcal bacteraemia: epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance.
    Shaked H; Carmeli Y; Schwartz D; Siegman-Igra Y
    Scand J Infect Dis; 2006; 38(11-12):995-1000. PubMed ID: 17148067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance.
    Jang HC; Lee S; Song KH; Jeon JH; Park WB; Park SW; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
    J Korean Med Sci; 2010 Jan; 25(1):3-8. PubMed ID: 20052340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rise of ampicillin-resistant Enterococcus faecium high-risk clones as a frequent intestinal colonizer in oncohaematological neutropenic patients on levofloxacin prophylaxis: a risk for bacteraemia?
    Sánchez-Díaz AM; Cuartero C; Rodríguez JD; Lozano S; Alonso JM; Rodríguez-Domínguez M; Tedim AP; Del Campo R; López J; Cantón R; Ruiz-Garbajosa P
    Clin Microbiol Infect; 2016 Jan; 22(1):59.e1-59.e8. PubMed ID: 26321668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-lactam antibiotics vs. vancomycin for the early treatment of enterococcal bacteraemia: A retrospective cohort study.
    Petersiel N; Bitterman R; Manaa A; Nashashibi L; Moskovich O; Geffen Y; Polak D; Braun E; Neuberger A; Paul M
    Int J Antimicrob Agents; 2019 Jun; 53(6):761-766. PubMed ID: 30954636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance.
    Bae KS; Shin JA; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    Infection; 2019 Jun; 47(3):417-424. PubMed ID: 30565009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing trend in enterococcal bacteraemia and vancomycin resistance in a tertiary care hospital in Croatia, 2017-2021.
    Todorić Z; Majdandžić I; Keretić Kregar T; Herljević Z; Ćorić M; Lešin J; Kuliš T; Mareković I
    Infect Dis (Lond); 2023 Jan; 55(1):9-16. PubMed ID: 36240424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study.
    Echeverria-Esnal D; Sorli L; Prim N; Conde-Estévez D; Mateu-De Antonio J; Martin-Ontiyuelo C; Horcajada JP; Grau S
    Int J Antimicrob Agents; 2019 Nov; 54(5):572-578. PubMed ID: 31476435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of a cohort of patients with Enterococcus spp. Bacteraemia. Risk factors associated to high-level resistance to aminoglycosides].
    García-Vázquez E; Albendín H; Hernández-Torres A; Canteras M; Yagüe G; Ruiz J; Gómez J
    Rev Esp Quimioter; 2013 Sep; 26(3):203-13. PubMed ID: 24080886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterococcal bacteraemia: a prospective study of 125 episodes.
    Gray J; Marsh PJ; Stewart D; Pedler SJ
    J Hosp Infect; 1994 Jul; 27(3):179-86. PubMed ID: 7963458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious Diseases Consultation Improves Treatment and Decreases Mortality by Enterococcal Bacteremia in Children.
    Furuichi M; Furuichi M; Horikoshi Y; Miyairi I
    Pediatr Infect Dis J; 2018 Sep; 37(9):856-860. PubMed ID: 29384980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases.
    Sandoe JA; Witherden IR; Au-Yeung HK; Kite P; Kerr KG; Wilcox MH
    J Antimicrob Chemother; 2002 Oct; 50(4):577-82. PubMed ID: 12356804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose Gentamicin for Uncomplicated Enterococcus faecalis Bacteremia May be Nephrotoxic in Children.
    Ibrahim SL; Zhang L; Brady TM; Hsu AJ; Cosgrove SE; Tamma PD
    Clin Infect Dis; 2015 Oct; 61(7):1119-24. PubMed ID: 26082503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.